Calamos Advisors LLC Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Calamos Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 01, 2022	SELL	$83.14 - $145.99 $2.31 Million - $4.06 Million	-27,800 Closed	0 $0
Q1 2022 May 03, 2022	BUY	$110.08 - $142.92 $3.06 Million - $3.97 Million	27,800 New	27,800 $3.3 Million
Q1 2021 Apr 12, 2021	SELL	$64.07 - $91.75 $1.37 Million - $1.96 Million	-21,361 Closed	0 $0
Q4 2020 Jan 27, 2021	BUY	$65.07 - $98.24 $246,159 - $371,641	3,783 Added 21.52%	21,361 $1.83 Million
Q3 2020 Oct 26, 2020	BUY	$59.04 - $77.95 $1.04 Million - $1.37 Million	17,578 New	17,578 $1.14 Million

565K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $2.49B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Calamos Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Calamos Advisors LLC with notifications on news.